Showing results (1091-1100 of 1,530) with videos related to
Sort By:
Pageof 153
Scientific Reports|October 18, 2017
Tissue and plasma levels of galectins in patients with high grade serous ovarian carcinoma as new predictive biomarkersMarilyne Labrie, Lorenna Oliveira Fernandes De Araujo, Laudine Communal, et al.Journal of Consulting and Clinical Psychology|October 3, 2007
The epidemiology of psychiatric disorders among repeat DUI offenders accepting a treatment-sentencing optionHoward J Shaffer, Sarah E Nelson, Debi A LaPlante, et al.The Journal of Clinical Endocrinology and Metabolism|October 9, 2004
Specificity and regioselectivity of the conjugation of estradiol, estrone, and their catecholestrogen and methoxyestrogen metabolites by human uridine diphospho-glucuronosyltransferases expressed in endometriumJohanie Lépine, Olivier Bernard, Marie Plante, et al.Research Quarterly for Exercise and Sport|October 19, 2007
Sports betting and other gambling in athletes, fans, and other college studentsToben F Nelson, Richard A LaBrie, Debi A LaPlante, et al.Applied and Environmental Microbiology|September 27, 2015
A virulent phage infecting Lactococcus garvieae, with homology to Lactococcus lactis phagesGiovanni Eraclio, Denise M Tremblay, Alexia Lacelle-Côté, et al.Addictive Behaviors|January 9, 2025
A longitudinal examination of factors predicting maternal permissiveness toward underage student drinking across the first three years of collegeOliver J Hatch, Bradley M Trager, Joseph W LaBrie, et al.Birth Defects Research. Part B, Developmental and Reproductive Toxicology|November 19, 2010
Effects of an antagonist of neurokinin receptors 1, 2 and 3 on reproductive hormones in male beagle dogsBrian P Enright, Michael W Leach, Georges Pelletier, et al.Climacteric : the Journal of the International Menopause Society|December 17, 2014
Decreased efficacy of twice-weekly intravaginal dehydroepiandrosterone on vulvovaginal atrophyC Bouchard, F Labrie, D F Archer, et al.Menopause (New York, N.Y.)|May 14, 2009
Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophyFernand Labrie, David Archer, Céline Bouchard, et al.Menopause (New York, N.Y.)|May 9, 2009
Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal womenFernand Labrie, David Archer, Céline Bouchard, et al.Pageof 153